Light Mode
$107.77 ↑ +0.00 (+0.00%) Trading Up from the previous close of $107.77, $1.22 below the day’s high of $108.99
+23.03 (+27.18%) / 6M
Momentum, market sentiment, and recent alerts
BLLN reads very good: price sits above both the 20- and 200-day averages, the 12-month move is -1.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.